Abnormal expression of insulin-like growth factor (IGF) binding proteins (IGFBPs) was detected in diabetes and could be used as a sensitive marker of insulin resistance defined as decreased sensitivity and/or responsiveness to metabolic actions of insulin promoting glucose disposal (Ruan and Lai, 2010). The gene discussed is INS; the disease is diabetes mellitus.